Catalent
CTLT
#1825
Rank
โ‚น1.110 T
Marketcap
โ‚น6,115
Share price
0.00%
Change (1 day)
28.40%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น609.80. In 2023 the company made an earnings per share (EPS) of -โ‚น655.08 a decrease over its 2022 EPS that were of โ‚น218.68.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-19.53%
2023-โ‚น655.08-399.56%
2022โ‚น218.68-30.58%
2021โ‚น315.0279.67%
2020โ‚น175.33114.12%
2019โ‚น81.88-15%
2018โ‚น96.3375.44%
2017โ‚น54.91-22.97%
2016โ‚น71.29-59.56%
2015โ‚น176.29282.05%
2014โ‚น46.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น65.51-89.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น44.31-107.27%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น72.25-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น142.58-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA